Literature DB >> 24504632

Stable marital relationship protects men from oral and genital HPV infections.

K M Kero1, J Rautava, K Syrjänen, O Kortekangas-Savolainen, S Grenman, S Syrjänen.   

Abstract

Human papillomavirus (HPV) infections are associated with sexual behavior. Changes in the sexual habits of couples and their impact on male genital and oral HPV infections were determined during 7 years of follow-up (FU). At baseline and 7 years FU, urethral, semen/penile, and oral samples were collected from 46 men and cervical and oral samples of their spouses for HPV DNA detection. Demographic data and risk factors of spouses were recorded by questionnaire at both time points and analyzed for concordance. HPV genotyping was done with the Multimetrix® kit. At baseline, 29.5 % of the male genital and 11 % of their oral samples tested positive. Incident genital HPV infection was found in 23 % and oral infection in 10.9 % of men. Genotype-specific persistence was detected in one man (HPV53) in genital samples. Moderate to almost perfect concordance of changes in sexual habits during FU among spouses were found. Changing partners [p = 0.028; odds ratio (OR) = 15; 95 % confidence interval (CI) 1.355-166.054] and marital status (p = 0.001; 95 % CI 0.000-0.002) increased the risk of incident genital HPV infections. The overall outcome of genital HPV disease in men was linked to the frequency of sexual intercourse (p = 0.023; 95 % CI 0.019-0.026) and changes in marital status (p = 0.022; 95 % CI 0.019-0.026), while oral HPV infections were associated with the number of sexual partners (p = 0.047; 95 % CI 0.041-0.052). Taken together, asymptomatic genital HPV infections among the men were common. The risk of incident genital HPV infections increased among men reporting a change of sexual partner during FU, implicating that a stable marital relationship protects against oral and genital HPV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504632     DOI: 10.1007/s10096-014-2061-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

2.  Bead-based multiplex genotyping of human papillomaviruses.

Authors:  Markus Schmitt; I G Bravo; Peter J F Snijders; Lutz Gissmann; Michael Pawlita; Tim Waterboer
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

3.  Genital human papillomavirus (HPV) concordance in heterosexual couples.

Authors:  Alan G Nyitray; Lynette Menezes; Beibei Lu; Hui-Yi Lin; Dan'elle Smith; Martha Abrahamsen; Mary Papenfuss; Christine Gage; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

4.  Human papillomavirus type distribution among heterosexual couples.

Authors:  Andrew T Abalos; Robin B Harris; Alan G Nyitray; Amy Mitchell; Patricia A Thompson; Anna R Giuliano; Francisco Garcia
Journal:  J Low Genit Tract Dis       Date:  2012-01       Impact factor: 1.925

5.  Meta-analysis of human papillomavirus infection concordance.

Authors:  Paul L Reiter; William F Pendergraft; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-10       Impact factor: 4.254

6.  Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland.

Authors:  Marjut A M Rintala; Seija E Grénman; Mirja H Puranen; Erika Isolauri; Ulla Ekblad; Pentti O Kero; Stina M Syrjänen
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.

Authors:  Karolina Louvanto; Marjut Anne Rintala; Kari Juhani Syrjänen; Seija Elisa Grénman; Stina Marita Syrjänen
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

8.  Urine versus brushed samples in human papillomavirus screening: study in both genders.

Authors:  Kathleen D'Hauwers; Christophe Depuydt; John-Paul Bogers; Michel Stalpaert; Annie Vereecken; Jean-Jacques Wyndaele; Wiebren Tjalma
Journal:  Asian J Androl       Date:  2007-09       Impact factor: 3.285

9.  Risk factors for anogenital human papillomavirus infection in men.

Authors:  Carrie M Nielson; Robin B Harris; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Roberto Flores; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

10.  Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.

Authors:  Zizipho Z A Mbulawa; David Coetzee; Dianne J Marais; Mercy Kamupira; Eugene Zwane; Bruce Allan; Deborah Constant; Jennifer R Moodley; Margaret Hoffman; Anna-Lise Williamson
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

View more
  10 in total

1.  Changing Places and Partners: Associations of Neighborhood Conditions With Sexual Network Turnover Among African American Adults Relocated From Public Housing.

Authors:  Sabriya L Linton; Hannah L F Cooper; Ruiyan Luo; Conny Karnes; Kristen Renneker; Danielle F Haley; Emily F Dauria; Josalin Hunter-Jones; Zev Ross; Gina M Wingood; Adaora A Adimora; Loida Bonney; Richard Rothenberg
Journal:  Arch Sex Behav       Date:  2016-02-29

2.  Genotype-specific concordance of oral and genital human papillomavirus infections among marital couples is low.

Authors:  K Kero; J Rautava; K Louvanto; K Syrjänen; S Grenman; S Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

3.  Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study.

Authors:  Ralf B Uken; Oliver Brummer; Carolin von Schubert-Bayer; Thomas Brodegger; Ingo U Teudt
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-09       Impact factor: 2.503

Review 4.  The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.

Authors:  Sylvia Taylor; Eveline Bunge; Marina Bakker; Xavier Castellsagué
Journal:  BMC Infect Dis       Date:  2016-06-14       Impact factor: 3.090

Review 5.  Oral manifestations of human papillomavirus infections.

Authors:  Stina Syrjänen
Journal:  Eur J Oral Sci       Date:  2018-10       Impact factor: 2.612

6.  Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review.

Authors:  Kelsey H Jordan; Chloe M Beverly Hery; Xiaochen Zhang; Electra D Paskett
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

7.  Sequential acquisition of human papillomavirus infection between genital and oral anatomic sites in males.

Authors:  Brittney L Dickey; Wenyi Fan; Deepti Bettampadi; Richard R Reich; Bradley Sirak; Martha Abrahamsen; Maria Luiza Baggio; Lenice Galan; Roberto Carvalho Silva; Jorge Salmerón; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Int J Cancer       Date:  2021-07-14       Impact factor: 7.316

Review 8.  Significance of Human Papillomavirus in Head and Neck Cancers.

Authors:  Kristy Lynn Boggs
Journal:  J Adv Pract Oncol       Date:  2015-05-01

9.  The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan.

Authors:  Dabao Xu; Xingping Zhao; Bingsi Gao; Yu-Ligh Liou; Yang Yu; Lingxiao Zou; Waixing Li; Huan Huang; Aiqian Zhang
Journal:  Sci Rep       Date:  2021-07-23       Impact factor: 4.379

10.  The association of HLA-G polymorphism with oral and genital HPV infection in men.

Authors:  Nelli T Suominen; Anna J Jaakola; Michel Roger; Marie-Claude Faucher; Kari J Syrjänen; Seija E Grénman; Stina M Syrjänen; Karolina Louvanto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-10-25       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.